Probity Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.5M | Sell |
|
|||||
|
2025
Q1 | $1.56M | Sell |
|
|||||
|
2024
Q4 | $1.33M | Sell |
|
|||||
|
2024
Q3 | $1.27M | Buy |
|
|||||
|
2024
Q2 | $940K | Buy |
|
|||||
|
2024
Q1 | $841K | Sell |
|
|||||
|
2023
Q4 | $944K | Buy |
|
|||||
|
2023
Q3 | $769K | Buy |
|
|||||
|
2023
Q2 | $732K | Buy |
|
|||||
|
2022
Q4 | $775K | Sell |
|
|||||
|
2022
Q3 | $571K | Sell |
|
|||||
|
2022
Q2 | $656K | Buy |
|
|||||
|
2022
Q1 | $620K | Sell |
|
|||||
|
2021
Q4 | $769K | Buy |
|
|||||
|
2021
Q3 | $705K | Buy |
|
|||||
|
2021
Q2 | $647K | Buy |
|
|||||
|
2021
Q1 | $511K | Buy |
|
|||||
|
2020
Q3 | $309K | Buy |
|
|||||
|
2020
Q2 | $302K | Buy |
|